지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Clinical significance of PIVKA-II levels after liver transplantation for hepatocellular carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Clinical and Molecular Hepatology
2023 .04
AFP, PIVKA-II, AFP-L3 alone and in combination for early detection of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter analysis
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
간세포암의 진단과 치료에서 종양표지자의 역할
대한내과학회지
2020 .02
The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma
Gut and Liver
2015 .01
Usefulness of sarcopenia in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
대한외과학회 학술대회 초록집
2019 .10
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
Clinical and Molecular Hepatology
2020 .01
Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma
영남의대학술지
2015 .01
Laparoscopic liver resection versus percutaneous radiofrequency ablation for single small hepatocellular carcinoma (≤ 3 cm): Optimal indication based on the tumor size and the level of PIVKA-II
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Laparoscopic liver resection versus percutaneous radiofrequency ablation for single small hepatocellular carcinoma (≤3cm): Optimal indication based on the tumor size and the level of PIVKA-II
대한임상종양학회 학술대회지
2022 .02
Prognostic value of preoperative protein-induced vitamin K absence or antagonist II after liver resection for hepatitis B-related hepatocellular carcinoma: a nationwide multicenter study
Annals of Surgical Treatment and Research
2022 .11
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Clinical and Molecular Hepatology
2015 .01
Combined hyperthermia and chemotherapy as a synergistic anticancer treatment
Journal of Pharmaceutical Investigation
2019 .01
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
Cancer Research and Treatment
2016 .01
The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients
Annals of Hepato-Biliary-Pancreatic Surgery
2015 .11
The clinical management of hepatocellular carcinoma in China: Progress and challenges
Clinical and Molecular Hepatology
2023 .04
Effect of autophagy modulation on sorafenib-induced cytotoxicity in hepatocellular carcinoma cells
한국실험동물학회 학술발표대회 논문집
2019 .01
Current understanding of modulated electro-hyperthermia in cancer treatment
고신대학교 의과대학 학술지
2024 .09
An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib
Annals of Hepato-Biliary-Pancreatic Surgery
2015 .02
Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib
Yonsei Medical Journal
2017 .01
0